Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Medplus Health Services informed stock exchanges that its subsidiary, Optival Health Solutions Private Limited, received a 7-day suspension order for the drug license of one store located at Bhimavaram P P Road in Andhra Pradesh. The order was issued by the Assistant Director, Drugs Control Administration, Eluru & West Godavari District, under Rule 65 of the Drugs and Cosmetics Act, 1940, and was received on March 20, 2026. The company estimates a potential revenue loss of only Rs 1.93 lakhs from this action. This affects just one store out of Medplus's large retail network.
The impact is negligible for shareholders — it's a minor, short-term license suspension of a single store with a revenue impact of under ₹2 lakhs, which is immaterial to the company's overall operations and financials.